QuidelOrtho Return on Tangible Equity 2010-2024 | QDEL
Current and historical return on tangible equity values for QuidelOrtho (QDEL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| QuidelOrtho Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $-2.05B | $-0.40B | 550.87% |
| 2024-09-30 | $-1.87B | $-0.38B | 494.90% |
| 2024-06-30 | $-1.86B | $-0.40B | 470.29% |
| 2024-03-31 | $-1.77B | $-0.31B | 417.50% |
| 2023-12-31 | $-0.01B | $-0.42B | 2.05% |
| 2023-09-30 | $0.01B | $-0.45B | -2.37% |
| 2023-06-30 | $0.05B | $-0.50B | -7.12% |
| 2023-03-31 | $0.12B | $-0.57B | -16.19% |
| 2022-12-31 | $0.55B | $-0.67B | -662.24% |
| 2022-09-30 | $0.81B | $-0.79B | 176.93% |
| 2022-06-30 | $1.01B | $-0.87B | 105.73% |
| 2022-03-31 | $1.01B | $1.99B | 71.40% |
| 2021-12-31 | $0.70B | $1.49B | 60.08% |
| 2021-09-30 | $0.88B | $1.19B | 86.87% |
| 2021-06-30 | $0.90B | $0.97B | 110.34% |
| 2021-03-31 | $0.95B | $1.04B | 155.79% |
| 2020-12-31 | $0.81B | $0.87B | 212.60% |
| 2020-09-30 | $0.37B | $0.38B | 204.41% |
| 2020-06-30 | $0.16B | $0.14B | 161.04% |
| 2020-03-31 | $0.09B | $0.13B | 136.96% |
| 2019-12-31 | $0.07B | $0.08B | 339.53% |
| 2019-09-30 | $0.07B | $0.04B | -394.67% |
| 2019-06-30 | $0.07B | $0.01B | -110.84% |
| 2019-03-31 | $0.07B | $-0.04B | -62.20% |
| 2018-12-31 | $0.07B | $-0.09B | -51.39% |
| 2018-09-30 | $0.04B | $-0.13B | -18.41% |
| 2018-06-30 | $0.02B | $-0.16B | -13.96% |
| 2018-03-31 | $0.01B | $-0.20B | -13.54% |
| 2017-12-31 | $-0.01B | $-0.31B | 300.00% |
| 2017-09-30 | $-0.01B | $0.10B | -6.14% |
| 2017-06-30 | $0.00B | $0.09B | -1.07% |
| 2017-03-31 | $0.00B | $0.11B | 3.31% |
| 2016-12-31 | $-0.01B | $0.09B | -16.77% |
| 2016-09-30 | $-0.01B | $0.08B | -13.68% |
| 2016-06-30 | $-0.01B | $0.08B | -12.90% |
| 2016-03-31 | $-0.01B | $0.08B | -12.81% |
| 2015-12-31 | $-0.01B | $0.11B | -5.26% |
| 2015-09-30 | $0.00B | $0.11B | 0.85% |
| 2015-06-30 | $0.00B | $0.11B | -3.50% |
| 2015-03-31 | $0.00B | $0.13B | -1.86% |
| 2014-12-31 | $-0.01B | $0.12B | -8.33% |
| 2014-09-30 | $-0.01B | $0.09B | -16.33% |
| 2014-06-30 | $-0.01B | $0.09B | -14.86% |
| 2014-03-31 | $-0.01B | $0.09B | -9.15% |
| 2013-12-31 | $0.01B | $0.08B | 9.03% |
| 2013-09-30 | $0.02B | $0.07B | 20.20% |
| 2013-06-30 | $0.02B | $0.07B | 25.90% |
| 2013-03-31 | $0.02B | $0.09B | 26.56% |
| 2012-12-31 | $0.01B | $0.07B | 9.57% |
| 2012-09-30 | $0.00B | $0.05B | -6.59% |
| 2012-06-30 | $0.00B | $0.05B | -7.23% |
| 2012-03-31 | $0.00B | $0.04B | -8.89% |
| 2011-12-31 | $0.01B | $0.04B | 14.29% |
| 2011-09-30 | $0.01B | $0.04B | 16.90% |
| 2011-06-30 | $0.00B | $0.06B | 4.30% |
| 2011-03-31 | $0.00B | $0.06B | 52.17% |
| 2010-12-31 | $-0.01B | $-0.01B | 102.33% |
| 2010-09-30 | $0.01B | $-0.01B | 40.91% |
| 2010-06-30 | $0.03B | $-0.01B | 56.87% |
| 2010-03-31 | $0.03B | $-0.01B | 42.31% |
| 2009-12-31 | $0.03B | $0.12B | 31.81% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.531B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.641B | 27.61 |
| Boston Scientific (BSX) | United States | $152.191B | 38.10 |
| Stryker (SYK) | United States | $148.126B | 30.97 |
| EssilorLuxottica (ESLOY) | France | $127.448B | 0.00 |
| Medtronic (MDT) | Ireland | $110.055B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.786B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.281B | 27.46 |
| ResMed (RMD) | United States | $36.314B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.934B | 16.11 |
| Agilent Technologies (A) | United States | $32.944B | 21.76 |
| Terumo (TRUMY) | Japan | $28.086B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.536B | 16.92 |
| Insulet (PODD) | United States | $22.286B | 87.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.433B | 12.48 |
| Baxter (BAX) | United States | $16.360B | 12.22 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.190B | 24.31 |
| Lantheus Holdings (LNTH) | United States | $5.502B | 13.88 |
| Prestige Consumer Healthcare (PBH) | United States | $4.350B | 19.43 |
| Perrigo (PRGO) | Ireland | $3.711B | 9.40 |
| ICU Medical (ICUI) | United States | $3.552B | 26.20 |
| Haemonetics (HAE) | United States | $3.528B | 15.37 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.144B | 26.13 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 18.12 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| AtriCure (ATRC) | United States | $1.575B | 0.00 |
| Neogen (NEOG) | United States | $1.411B | 18.06 |
| AdaptHealth (AHCO) | United States | $1.229B | 12.48 |
| Kestra Medical Technologies (KMTS) | United States | $1.211B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.152B | 25.91 |
| BioLife Solutions (BLFS) | United States | $1.135B | 0.00 |
| InMode (INMD) | Israel | $1.043B | 9.55 |
| Phibro Animal Health (PAHC) | United States | $0.992B | 12.69 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.552B | 4.58 |
| Curaleaf Holdings (CURLF) | Canada | $0.545B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.462B | 0.00 |
| Surmodics (SRDX) | United States | $0.387B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.357B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Sanara MedTech (SMTI) | United States | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.268B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.261B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.70 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Quanterix (QTRX) | United States | $0.222B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.29 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 51.94 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.82 |
| Jin Medical (ZJYL) | China | $0.141B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Agape ATP (ATPC) | $0.083B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.76 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |